PF-07209326

N/A

Report date: 2024/11/18 15:08:55

Base Information

Drug NamePF-07209326
Drug Alias NamePF-07209326
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionSelectin E inhibitors
TargetsSelectin E
Therapy Area/IndicationsAnemia, Sickle Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesPfizer Inc
Inactive CompaniesN/A
Active IndicationsAnemia, Sickle Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A